VERU VERU INC.

VERU financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 863894 Exchange: Nasdaq SIC: 2834 (Pharmaceutical Preparations) Latest filing: 10-Q filed Aug 10, 2026 Data checked: Oct 21, 2026
Showing 3 of 17 annual and 0 of 64 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$64.10M (Mar 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
WI
Fiscal Year End
September (0930)
Phone
3125959123
EIN
391144397
Headquarters
MIAMI, FL, 33127
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: FEMALE HEALTH CO (1996–2017)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
-
Net Income
$-13.61M
Total Assets
$37.03M
Total Equity
$28.38M
Total Debt
-
Free Cash Flow
$-26.04M
Ratios
Return on Equity
-48%
Return on Assets
-36.8%
Current Ratio
4.42x
FCF / Assets
-70.3%

▼ FY 2025 Summary Analysis

Annual report ending Sep 30, 2025

Overview and Growth

VERU INC. recorded fiscal 2025 net loss of $22.73M. At period end, total assets were $29.84M, framing the scale of the company’s operating and financing commitments.

Profitability

The company recorded an operating loss of $24.75M after the reported operating expense base. The company ended the period with a net loss of $22.73M, extending the operating result through all remaining items. Negative EBITDA totaled $24.60M, confirming that the earnings deficit remained before depreciation and amortization. The reported income-tax provision was $0.00, the amount recognized between pretax income and the final net-income result. The net loss equaled 124.0% of period-end equity, showing the deficit relative to book capital. The loss-to-assets relationship was 76.2%, placing the bottom-line deficit against the company’s resource base. Compared with a $37.80M net loss in fiscal 2024, the current loss improved to $22.73M.

Liquidity and Capital Structure

The company held $29.84M of assets against $11.50M of liabilities and $18.33M of equity, revealing how the asset base was financed. Current assets were $18.92M against $7.79M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. The current ratio was 2.43x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. The company held $15.79M in cash and equivalents, a narrower liquidity measure than total current assets. Measured only with cash and equivalents, coverage of current liabilities was 202.9%, excluding receivables and other current assets. The equity-to-assets relationship was 61.4%, placing book capital against the total resource base. Liabilities represented 38.6% of total assets, quantifying the liability-funded share of the company’s resource base. Measured against total assets, cash and equivalents represented 52.9%, a balance-sheet composition measure rather than a liquidity forecast. The asset base changed 50.6% from $60.42M in fiscal 2024, leaving current total assets lower year over year. Book equity was 43.3% lower than fiscal 2024 equity of $32.32M, showing how shareholder capital changed year over year. The reported cash balance changed 36.6% from $24.92M in fiscal 2024, ending lower year over year.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $30.04M, rather than cash generation from operations. Capital spending of $1.08K added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. Operating cash flow and capital spending combined to leave a $30.04M cash deficit after capital spending. The cash deficit after capital spending represented 100.7% of the period-end asset base. Cash absorbed by operations increased from $21.68M in fiscal 2024 to $30.04M.
Based on the annual report for the fiscal year ending Sep 30, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for VERU INC.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue - $16.89M $16.30M
Cost of Revenue - $11.03M $8.73M
Gross Profit - $5.85M $7.57M
OPERATING EXPENSES
R&D Expense $15.59M $12.78M $51.20M
SG&A Expense $19.94M $31.18M $48.06M
Other Operating Expenses (derived) - $-1.94M $2.09M
Operating Income $-24.75M $-36.17M $-93.78M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $2.43M
Other Income/Expense $768.38K $1.09M $573.77K
Pretax Income - - $-92.67M
Income Tax $0 $0 $480.21K
Net Income $-22.73M $-37.80M $-93.15M
PER SHARE & SUPPLEMENTAL
EBITDA $-24.60M $-35.90M $-93.51M
Depreciation & Amortization $152.11K $268.18K $269.87K
Balance Sheet
ASSETS
Cash & Equivalents $15.79M $24.92M $9.63M
Accounts Receivable - $3.96M $4.51M
Inventory - $4.14M $6.70M
Other Current Assets $595.25K $1.78M $1.10M
Current Assets $18.92M $35.22M $22.93M
PP&E (Net) $364.81K $1.28M $1.65M
Goodwill $6.88M $6.88M $6.88M
Intangible Assets - $0 $5.95K
Other Noncurrent Assets $930.85K $1.13M $1.51M
Noncurrent Assets $10.92M $25.20M $27.09M
Total Assets $29.84M $60.42M $50.02M
LIABILITIES
Accounts Payable $3.12M $3.04M $12.93M
Other Current Liabilities - - $1.96M
Current Liabilities $7.79M $11.87M $17.81M
Other Noncurrent Liabilities $1.36M $4.46M $29.95K
Noncurrent Liabilities $3.72M $16.23M $12.53M
Total Liabilities $11.50M $28.10M $30.34M
EQUITY
Common Stock $148.69K $1.49M $939.66K
Additional Paid-in Capital $343.29M $333.79M $283.89M
Retained Earnings $-317.30M $-294.57M $-256.77M
Accumulated OCI $0 $-581.52K $-581.52K
Total Equity $18.33M $32.32M $19.68M
Total Liabilities & Equity $29.84M $60.42M $50.02M
SUPPLEMENTAL
Shares Outstanding 14.65M 14.64M -
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-30.04M $-21.68M $-88.01M
Capital Expenditures $1.08K $158.32K $665.70K
Cash from Investing $25.14M $146.21K $6.33M
Cash from Financing $-4.22M $36.83M $11.11M
Free Cash Flow $-30.04M $-21.84M $-88.68M
Beginning Cash (CFS) $24.92M $9.63M $80.19M
Net Change in Cash $-9.12M $15.29M $-70.57M
Effect of FX on Cash $0 $0 $0
Calculated Ending Cash $15.79M $24.92M $9.63M
Cash per BS $15.79M $24.92M $9.63M
Cash scope difference (CFS − BS) - - -
Cash per CFS $15.79M $24.92M $9.63M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

Is VERU INC. profitable?

No. VERU INC. reported $-13.61M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does VERU INC. generate free cash flow?

No. Free cash flow was $-26.04M for trailing twelve months. Operating cash flow was $-26.04M.